Sterling Investment Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Sterling Investment Counsel's ABBV Position: Q2 2026 in Review
Sterling Investment Counsel increased its AbbVie (ABBV) stake by 4.9% in Q2 2026, buying an estimated $92.7K and bringing the position to 9,241 shares worth $2.33M. The position accounts for 0.55% of the portfolio, ranked #29.
Sterling Investment Counsel first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Sterling Investment Counsel held 9,241 shares of AbbVie worth $2.33M as of Q2 2026.
- Sterling Investment Counsel bought 431 AbbVie shares in Q2 2026, an estimated $92.7K.
- AbbVie made up 0.55% of Sterling Investment Counsel's portfolio in Q2 2026, its #29 holding.
- Sterling Investment Counsel first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Sterling Investment Counsel's 13F filing for Q2 2026, filed 20 Jul 2026.